KRIBIOLISA Anti-Ocrelizumab ELISA includes features like:
– Ready to use protocol with break-apart wells for ease of use
– Standardisation and High Reproducibility
– Lot to Lot Consistency
– Accuracy and Precision
Validated against seven points for a ?GOLD RING? Standard Quality ELISA – the benchmark sign for Krishgen Quality. KRIBIOLISA ELISA kit is used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies / recombinant proteins – capture and detection to ensure a high degree of sensitivity and specificity in the estimation of the analyte. Extensive validation has been done on these kits. Please ask for our validation guide if not availableon our product page. Incase you wish us to customize the kit, connect with us at sales1@krishgen.com
Background: This ELISA detects Neutralizing Antibodies to Ocrelizumab antibodies in human serum or plasma. Ocrelizumab is an anti-EGFR monoclonal antibody, and the presence of ADAs may influence pharmacokinetics and treatment response. The assay supports immunogenicity evaluation in oncology clinical studies.